Nagle, S. J., Shah, N. N., Ganetsky, A., Landsburg, D. J., Nasta, S. D., Mato, A., . . . Svoboda, J. (2017). Long-term outcomes of rituximab, temozolomide and high-dose methotrexate without consolidation therapy for lymphoma involving the CNS. Int J Hematol Oncol.
Stile di citazione ChicagoNagle, Sarah J., et al. "Long-term Outcomes of Rituximab, Temozolomide and High-dose Methotrexate Without Consolidation Therapy for Lymphoma Involving the CNS." Int J Hematol Oncol 2017.
Citazione MLANagle, Sarah J., et al. "Long-term Outcomes of Rituximab, Temozolomide and High-dose Methotrexate Without Consolidation Therapy for Lymphoma Involving the CNS." Int J Hematol Oncol 2017.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.